Hints and tips:
...A veteran of the pharmaceuticals industry, he experienced a big merger while working for SmithKline Beecham when it combined with Glaxo Wellcome in 2000....
...They gathered data to help make the case to the SmithKline board to fund their general adjuvant-based approach....
...Jean-Pierre Garnier recalls his concern when he took over as chief executive of GSK, following its creation from the merger of Glaxo Wellcome and SmithKline Beecham in 2000, and began to study in detail...
International Edition